Anti-Collagen type VII, IgG Antibodies, Serum
Use
This test is used as an initial screening tool in the diagnosis of epidermolysis bullosa acquisita and other immunobullous diseases mediated by collagen VII. The presence of IgG antibodies against collagen type VII can help identify these conditions, which are characterized by blisters and erosions that may heal with scarring.
Special Instructions
Not provided.
Limitations
The assay should be used in conjunction with other diagnostic procedures and interpreted within the clinical context of the patient. Performance characteristics have not been established for specimens other than serum.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
Collagen type VII
Protein
LOINC Codes
- 94096-5 - CollagenVII IgG SerPl Ql IA
Result Turnaround Time
1-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
0.5 mL
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial. Preferred collection container is a serum gel tube; a red top tube is acceptable.
Causes for Rejection
None due to gross hemolysis, lipemia, or icterus.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 30 days |